Cargando…
Richter Transformation: Clinical Manifestations, Evaluation, and Management
Richter transformation is a devastating and rare but not uncommon development of an aggressive B-cell lymphoma in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Prognosis is dismal, with survival generally in the realm of months to a couple of years. Many patients progress...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328451/ https://www.ncbi.nlm.nih.gov/pubmed/35910504 http://dx.doi.org/10.6004/jadpro.2022.13.5.6 |
_version_ | 1784757722662567936 |
---|---|
author | Douglas, Melanie |
author_facet | Douglas, Melanie |
author_sort | Douglas, Melanie |
collection | PubMed |
description | Richter transformation is a devastating and rare but not uncommon development of an aggressive B-cell lymphoma in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Prognosis is dismal, with survival generally in the realm of months to a couple of years. Many patients progress quickly after traditional first-line immunochemotherapy. Nonetheless, novel therapies are on the horizon. It is important that the advanced practitioner have awareness and knowledge of this condition in order to furnish a crucial timely diagnosis and to provide appropriate treatment. |
format | Online Article Text |
id | pubmed-9328451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Harborside Press LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-93284512022-07-29 Richter Transformation: Clinical Manifestations, Evaluation, and Management Douglas, Melanie J Adv Pract Oncol Grand Rounds Richter transformation is a devastating and rare but not uncommon development of an aggressive B-cell lymphoma in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Prognosis is dismal, with survival generally in the realm of months to a couple of years. Many patients progress quickly after traditional first-line immunochemotherapy. Nonetheless, novel therapies are on the horizon. It is important that the advanced practitioner have awareness and knowledge of this condition in order to furnish a crucial timely diagnosis and to provide appropriate treatment. Harborside Press LLC 2022-07 2022-07-27 /pmc/articles/PMC9328451/ /pubmed/35910504 http://dx.doi.org/10.6004/jadpro.2022.13.5.6 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Grand Rounds Douglas, Melanie Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title | Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title_full | Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title_fullStr | Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title_full_unstemmed | Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title_short | Richter Transformation: Clinical Manifestations, Evaluation, and Management |
title_sort | richter transformation: clinical manifestations, evaluation, and management |
topic | Grand Rounds |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328451/ https://www.ncbi.nlm.nih.gov/pubmed/35910504 http://dx.doi.org/10.6004/jadpro.2022.13.5.6 |
work_keys_str_mv | AT douglasmelanie richtertransformationclinicalmanifestationsevaluationandmanagement |